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Abstract
Multiple Sclerosis (MS) causes neurologic disability due to inflammation, demyelination, and neurodegeneration.
Immunosuppressive treatments can modify the disease course but do not effectively promote remyelination or
prevent long term neurodegeneration. As a novel approach to mitigate chronic stage pathology, we tested
transplantation of mouse induced neural stem cells (iNSCs) into the chronically demyelinated corpus callosum (CC)
in adult mice. Male C57BL/6 mice fed 0.3% cuprizone for 12 weeks exhibited CC atrophy with chronic
demyelination, astrogliosis, and microglial activation. Syngeneic iNSCs were transplanted into the CC after ending
cuprizone and perfused for neuropathology 2 weeks later. Magnetic resonance imaging (MRI) sequences for
magnetization transfer ratio (MTR), diffusion-weighted imaging (T2), and diffusion tensor imaging (DTI) quantified
CC pathology in live mice before and after iNSC transplantation. Each MRI technique detected progressive CC
pathology. Mice that received iNSCs had normalized DTI radial diffusivity, and reduced astrogliosis post-imaging. A
motor skill task that engages the CC is Miss-step wheel running, which demonstrated functional deficits from
cuprizone demyelination. Transplantation of iNSCs resulted in marked recovery of running velocity. Neuropathology
after wheel running showed that iNSC grafts significantly increased host oligodendrocytes and proliferating
oligodendrocyte progenitors, while modulating axon damage. Transplanted iNSCs differentiated along astrocyte
and oligodendrocyte lineages, without myelinating, and many remained neural stem cells. Our findings
demonstrate the applicability of neuroimaging and functional assessments for pre-clinical interventional trials
during chronic demyelination and detect improved function from iNSC transplantation. Directly reprogramming
fibroblasts into iNSCs facilitates the future translation towards exogenous autologous cell therapies.
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Introduction
Recent epidemiological data identified nearly a million
adults in the United States alone who are living with a
diagnosis of multiple sclerosis (MS), which is almost
double prior estimates [1]. This increased appreciation
of the MS burden to patients and society emphasizes the
urgent need for developing effective treatments. Early in
their disease course, relapsing-remitting MS patients
often experience periods of autoimmune remission ac-
companied by spontaneous remyelination [2]. In con-
trast, the progressive pathology of chronic MS results in
sclerotic lesions with axon loss and failed remyelination
[3]. Novel treatment strategies are critical to suppress
immune attacks, overcome factors limiting remyelina-
tion, and prevent neurodegeneration [4–6]. The current
studies test a novel neural stem cell-based therapy in an
experimental model of chronic demyelination.
Immature oligodendrocyte lineage cells persist in adult
human white matter but fail to mature and remyelinate in
chronic MS lesions [7–9]. Among interventions to pro-
mote remyelination, anti-Lingo-1 and clemastine have ad-
vanced to clinical trials in relapsing MS patients [10, 11].
Anti-Lingo-1 and clemastine act by modulating molecular
signals that regulate oligodendrocyte differentiation [12–
14]. Pre-clinical studies, including those for anti-Lingo-1
and clemastine, have often used acute demyelination
models that undergo efficient spontaneous remyelination
by endogenous oligodendrocyte progenitor cells (OPCs)
[12, 14, 15]. The outcome of these acute stage studies is
then based on accelerating remyelination to enhance re-
covery of function and protect demyelinated axons from
further damage. However, acute demyelination models
cannot effectively evaluate treatment strategies for chronic
demyelination and neurodegeneration [16].
The cuprizone (CPZ) model of corpus callosum (CC)
demyelination is well characterized for remyelination
studies [17, 18]. CPZ ingestion for 4–6 weeks produces
acute demyelination with robust OPC amplification and
extensive remyelination [19, 20]. In CPZ and other acute
demyelination models, multiple signaling molecules pro-
mote remyelination from newly generated oligodendro-
cytes [2, 21]. Prolonging CPZ ingestion for 10–12 weeks
produces chronic demyelination with progressive path-
ology, including CC atrophy, persistent astrogliosis, OP
depletion, and limited remyelination [20, 22–24]. Im-
portantly, CC atrophy correlates with functional out-
comes in MS patients [25, 26]. Relevant to modeling
sclerotic lesions, chronic CPZ lesions express molecules
associated with astrogliosis that inhibit OP differenti-
ation and limit remyelination [23, 27, 28].
The objective of the current study was to employ a
combination of translational approaches to evaluate in-
duced neural stem cell (iNSC) transplantation after
chronic demyelination. Direct conversion of mouse or
human somatic cells to generate iNSCs circumvents the
pluripotent stage associated with increased tumorigenesis
and genomic instability, with potential as an autologous
therapy [29–32]. To model an autologous set-up, we
transplanted syngeneic iNSCs into the CC after 12 weeks
of CPZ in two cohorts of mice. In one cohort, longitudinal
magnetic resonance imaging (MRI) demonstrated the pro-
gression of CC pathology throughout the course of CPZ
demyelination, and during recovery after iNSC transplant-
ation. In the second cohort, functional testing used Miss-
step wheel running to engage the CC and reveal motor
deficits after CPZ demyelination [33–35]. Following MRI
and behavioral assessments, brain tissue sections were ex-
amined for CC atrophy, remyelination, and cellular re-
sponses of both transplanted iNSCs and host endogenous
cells. Our work provides evidence ofimproved function
after iNSC transplantation together with technical ad-
vances for translational chronic CPZ model and may pave
the way for a novel therapeutic strategy to treat progres-
sive MS by autologous neural stem cell therapies.
Materials and methods
Experimental design and statistical analysis
The experiments were designed as pre-clinical trials to
test the effect of iNSC transplantation during chronic
CPZ demyelination. Experiments were carried out ac-
cording to the Animal Research Reporting: In Vivo Ex-
periments (ARRIVE) guidelines. Technique validation
was performed using pilot cohorts. Two parallel trial ex-
periments each used a non-invasive assessment, MRI
(structural) or behavior (functional), as the primary out-
come measure. A pre-determined study design was used
that stated inclusion/exclusion criteria, randomization
procedures, and statistical analyses. All experiments
were performed with blinding during implementation
and analysis. Sample size estimates were based on prior
experiments using each primary outcome measure (MRI
or behavior). To reduce variability due to the demyelin-
ation produced by CPZ, mice were split into groups bal-
anced by weights and assigned to treatment condition
using the Excel RAND command for randomization.
After completion of the primary outcome assessment,
mice in each experiment were perfused for neuropathol-
ogy and cell type analyses.
Timelines for the mouse cohorts are shown in the cor-
responding figures and mouse sample numbers are pro-
vided in each legend. A total of 100 mice were used
across the experiments in the study. Only male mice
were used since CPZ toxicity effects the estrus cycle so
that sex cannot be appropriately analyzed as a biological
variable [36]. Statistical analysis and graphing was per-
formed using GraphPad Prism software version 8.0
(RRID: SCR_002798). The values are shown as the
mean ± standard error of the mean (sem). Statistical
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significance was determined as p < 0.05. The experimen-
tal design and statistical analysis for each section is pro-
vided below with the technical methods for that study.
Mice and cuprizone model of demyelination
Mice were housed and cared for in accordance with the
National Institutes of Health Guide for the Care and Use
of Laboratory Animals. The study protocol was approved
by the Institutional Animal Care and Use Committee of
the Uniformed Services University of the Health Sci-
ences. Mice were socially housed in 27 cm × 16.5 cm ×
12.5 cm cages (2–5 mice per cage) with enrichment ob-
jects and maintained on a standard 12 h cycle of daytime
light (6:00–18:00). All procedures took place during the
daytime light cycle.
C57BL/6 J mice (RRID:IMSR_JAX:000664, Jackson La-
boratory, Bar Harbor, MA) at 8 weeks of age were fed
pellets containing 0.3% CPZ for 6 weeks or 12 weeks to
produce acute or chronic demyelination, respectively.
Milled CPZ powder (cat #14690; Sigma-Aldrich; St.
Louis, MO) was mixed as 0.3% CPZ in normal chow
(diet TD.01453; Harlan Teklad, Frederick, MD) to form
pellets that were refreshed every 2–3 days. A dose of
0.3% CPZ in pellets produces CC demyelination approxi-
mately equivalent to 0.2% CPZ powder in ground chow
[37–39]. Cohorts to be evaluated for remyelination re-
ceived normal chow pellets for an additional 2 weeks
after CPZ removal. Naïve mice continuously fed normal
chow pellets served as a control non-demyelinated con-
dition performed simultaneously along with CPZ treated
mice. Baseline weights at the start of CPZ or normal
chow feeding were similar within each cohort: MRI tech-
nical validation cohort (mean ± sem = naïve 25.25 ± 0.47
g; CPZ 25.25 ± 0.43 g), MRI iNSC transplant cohort
(CPZ veh 26.24 ± 0.42 g; CPZ iNSC 26.33 ± 0.37 g),
wheels iNSC transplant cohort (naïve veh 22.87 ± 0.40 g;
CPZ veh 23.76 ± 0.56 g; CPZ iNSC 23.76 ± 0.61 g). Mice
remained in good health and regained baseline weights
by the end of chronic CPZ administration.
Magnetic resonance imaging (MRI)
In vivo MRI was performed on a 7 T small animal (20
cm bore) Bruker BioSpec scanner equipped with 12 cm
diameter 650 mT/m gradient coils (Bruker BioSpin
GmbH, Reinstetten, Germany). MRI with T2 weighting,
magnetization transfer ratio (MTR), and diffusion tensor
imaging (DTI) was used for longitudinal in vivo analysis
of the effects of chronic CPZ ingestion and subsequent
iNSC transplantation in the CC. Prior to image acquisi-
tion, mice were separated into yoked pairs of similar
weight. During each image acquisition, mice were anaes-
thetized with 1% isoflurane. MRI slices were established
using a sagittal localizer so that seven coronal slices were
orientated perpendicular to the length of the CC and
each scan was aligned with the midline crossing of the
anterior commissure positioned in the same coronal
slice [40–42].
For DTI [43], a three-dimensional (3D) single-shot
echo planar imaging sequence (repetition time/echo
time [TR/TE] = 900/36msec; 1 repetition) was used to
acquire 4 unweighted (b = 0 s/mm2) and 2 diffusion-
weighted images (b = 600, 1200 s/mm2) in 14 noncollin-
ear diffusion gradient directions using a Stejskal-Tanner
diffusion preparation with parameters of Δ = 12 msec
and δ = 5msec, field of view (FOV) = 14 × 11.2 mm2,
matrix = 80 × 64 × 24, slice thickness = 750 μm, 24 slices,
voxels = 175 × 175 × 750 μm3. A whole brain T2 map
was generated using a two-dimensional rapid acquisition
with relaxation enhancement (2D RARE, corona [44])
with the following parameters: TR = 4000msec; TE = 10,
30, 50, 70, 90, 110 msec; RARE factor = 2, number of av-
erages (NA) = 4, FOV = 14 × 12 mm2, matrix = 112 ×
96 × 18, slice thickness = 750 μm, 18 slices, voxels =
125 × 125 × 750 μm3. For use in calculating the
magnetization transfer ratio (MTR) [45, 46], 2D RARE
sequence was used with TR = 6000 msec, TE = 20 msec,
RARE factor = 8, NA = 4, FOV = 14 × 12mm2, matrix =
112 × 96 × 18, voxels = 125 × 125 × 750 μm3, with satur-
ation (Ms) and without (Mo) using an offset saturation
pulse (2 kHz offset 66.7° flip angle). Body temperature was
maintained at 36 °C by circulating hot water. Respiration
and heart rate were monitored throughout each 2-h im-
aging session.
T2 and MTR maps along with T2 templates were gen-
erated from neuroimaging informatics technology initia-
tive (NIFTI) files and analyzed in either VivoQuant
(inviCRO, Boston, MA) (chronic CPZ) or MATLAB
(MathWorks, Natick, MA)(chronic CPZ + 2 weeks recov-
ery). The CC ROI was defined as extending from the
midline bilaterally to the point of ventral curvature in
the external capsule, as in our previous studies (Sullivan
et al. 2013 [47]; Yu et al. 2017 [42]). For each mouse, an
initial ROI was propagated across images using the T2
templates and the voxel placement checked/corrected
manually for each slice. The rostrocaudal extent of the
CC was contained within 7 slices. Slices 1 and 7 were
omitted to avoid regions of varying fiber directions to-
ward the genu and splenium. Slices 2–6 (approximately
1mm to − 2.5mm relative to bregma) were combined as
the full CC ROI. DTI data was analyzed with TORTOISE
software [48, 49]. Diffusion-weighted imaging artifacts, in-
cluding motion, eddy currents, and concomitant field dis-
tortions, were calculated and combined to enable the
image correction to be applied in a single step. Fractional
anisotropy (FA), Trace, and axial (AD) and radial (RD) dif-
fusivity maps were computed using a nonlinear tensor es-
timation with RESTORE option [50]. Diffusion direction-
encoded color (DEC) maps were generated from the
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TORTOISE software to demonstrate fiber orientation.
The CC ROIs were overlaid onto the DTI maps for further
quantitative analysis.
Technical validation for neuroimaging approach
An MRI study with post-imaging neuropathology evalu-
ated the MRI techniques for detection of chronic demye-
lination at the end of the chronic CPZ period, when
iNSCs will be transplanted in the subsequent experi-
ments. This longitudinal design compared naïve mice
(n = 6) that received normal chow pellets continuously
with CPZ treated mice (n = 6) at baseline (8 weeks of
age), 6 weeks ± CPZ (14 weeks of age), and 12 weeks ±
CPZ (20 weeks of age). Two-way ANOVA with repeated
measures was used to compare naïve vs. CPZ at each
time point, with Bonferroni multiple comparisons test.
Neuroimaging analysis of iNSC transplantation effect on CC
microstructure
An MRI longitudinal study with post-imaging neuropathol-
ogy evaluated the effect of iNSC transplantation on CC
microstructure during recovery after chronic CPZ. This lon-
gitudinal design compared CPZ treated mice injected with
vehicle (n = 5, one mouse died) or iNSCs (n = 6). Scans were
performed at baseline (8weeks of age before starting CPZ),
6 weeks CPZ, 12weeks CPZ, and then mice were returned
to normal chow pellets until the final scan at 14weeks. Mice
received iNSC or vehicle intracerebral injections 1 day after
the return to normal chow. Mice were scanned in sets of
four per day, which were balanced by weights prior to the
start of CPZ. After the week scan at 6weeks of CPZ, mice
within each set of four were randomly assigned, using Excel
RAND, to receive iNSC or vehicle injection. The T2 values
of the assigned groups were checked to ensure similar CPZ
effect within the cohorts at 6weeks. Two-way ANOVA with
repeated measures was used for within subjects comparisons
to baseline to evaluate CPZ pathology, and for comparison
of each time point for iNSC vs. vehicle, with Bonferroni cor-
rection for multiple comparisons.
Generation and characterization of mouse iNSCs
Mouse C57BL/6 iNSCs that ubiquitously express farne-
sylated green fluorescent protein (GFP) were generated
as previously detailed [29, 51]. Briefly, iNSCs were pro-
duced by direct conversion of mouse embryonic fibro-
blasts through constitutive expression of Sox2, Klf4, c-
Myc, and transient expression of Oct4. iNSCs were then
transduced with lentivirus containing a farnesylated GFP
construct to target GFP to the inner plasma membrane.
Prior to characterization and transplantation experi-
ments, iNSCs were cultured as an adherent monolayer,
as detailed previously [29, 51].
For in vitro characterization, iNSCs were cultured as
either free floating neurospheres in proliferation medium
or seeded onto glass coverslips coated with Matrigel™
(Cat# 356234 Corning, Corning, NY) for growth as ad-
herent monolayers in differentiation medium, as previ-
ously detailed [51]. Differentiation medium contained
NeuroCults basal medium (Cat# 05700, STEMCELL
Technologies, Cambridge, MA) with 10% differentiation
supplement (Cat# 05703, STEMCELL Technologies) and
100 units penicillin/0.1 mg streptomycin/mL (Cat#
15140122 Invitrogen, Waltham, MA). For immunocyto-
chemistry, neurosphere cultures were fixed on glass cov-
erslips in 4% paraformaldehyde (PFA, Sigma-Aldrich) 2%
sucrose in 1X PBS. Neurospheres were incubated with
primary antibodies for neural stem/progenitor cell
markers Sox2 (rabbit polyclonal, 1:200; Abcam, Cam-
bridge, MA, ab97959, RRID:AB_2341193) and Nestin
(chicken polyclonal, 1:200; Abcam, ab134017, RRID:AB_
2753197). Differentiation was examined using immuno-
labeling to detect markers of either the astroglial lineage
(glial fibrillary acidic protein, GFAP; rabbit polyclonal, 1:
100; DAKO; Carpinteria, CA, Z0334, RRID:AB_
10013382), the neuronal lineage (microtubule associated
protein-2, MAP-2, rabbit polyclonal, 1:200; Abcam;
ab32454, RRID:AB_776174), or the oligodendroglial
lineage (O4 mouse monoclonal, 1:10 [52]). PBS with
0.1% Triton-X 100 and 10% normal goat serum for 1 h
was used prior to all primary antibodies, but was not
used with O4 to prevent Triton-X 100 degradation of
the sulfatide epitope [7, 53]. Secondary antibodies used
were goat anti-rabbit IgG conjugated with AF647 (1:200;
Thermo Fisher, Waltham, MA; A-21245, RRID:AB_
2535813) to detect Sox2, and goat anti-chicken conju-
gated with AF555 (1:200; Thermo Fisher; A-21437,
RRID:AB_2535858) to detect Nestin, donkey anti-rabbit
IgG F(ab’)2 conjugated with Cy3 (1:400; Jackson Immu-
noResearch, West Grove, PA, 711–166-152, RRID:AB_
2313568) to detect GFAP, and goat anti-mouse IgM
conjugated with Cy3 (1:50; Jackson ImmunoResearch;
115–166-075, RRID:AB_2338707).
Technical validation for iNSCs preparations
Frozen iNSCs were thawed and cultured for amplification
and characterization for each transplantation experiment
cohort. An aliquot of each iNSC preparation used for
transplantation was analyzed to confirm neural stem cell
characteristics. For differentiation analysis, the number of
immunolabeled cells was counted in n ≥ 8 non-
overlapping fields per sample up to a total of n > 300 cells
per aliquot. For growth curve analysis, the total number of
cells was quantified after each passage of each subculture.
Cell transplantation into the corpus callosum
For all microinjections into the CC, mice were anaesthe-
tized with isoflurane (induction 3%, maintenance 2%)
and a small < 1.0 mm diameter burr hole was drilled into
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the skull. A Hamilton gas tight syringe (Cat# 7653–01;
Hamilton Company, Reno, NV) was used with adapters
(Cat# 55750–01; Hamilton Company) and a pulled glass
micropipette (outer diameter 50 μm) [54]. Each micro-
injection targeted the left CC using coordinates (− 1.0
AP, 0.5 ML, − 1.3DV) relative to bregma. An iNSC single
cell suspension of 1 × 104 cells in 1 μl of PBS, or PBS as
a vehicle control, was injected over a 5 min period.
Neurologic analysis with the miss-step running wheel assay
Starting the day after iNSC transplantation, and continu-
ing for 2 weeks, mice were singly housed in home cages
with a Miss-step running wheel and an optical sensor to
detect wheel revolutions (Mouse Miss-step Activity
Wheel system #80821, Lafayette Instruments, Lafayette,
IN). The Miss-step running wheels have 16 rungs miss-
ing from a standard wheel so that the remaining 22
rungs are distributed in an irregular interval pattern
[33]. Whiskers were clipped so that the mice learn to lo-
cate each rung by bringing the hind paw forward to
grasp the same rung as a forepaw [35]. Activity Wheel
Monitor software (Lafayette Instruments) counted wheel
revolutions at 6 min intervals during the light phase and
1min intervals during the dark phase. Results were
exported to a Microsoft Excel file every 24 h.
Technical validation for wheel running effects on
oligodendrocyte populations in CC
A study using acute CPZ, which undergoes extensive
spontaneous remyelination, tested the effect of the Miss-
step wheel exposure on the oligodendrocyte lineage re-
sponse in the CC. Mice were fed normal chow (naïve,
n = 6) or CPZ for 6 weeks to produce acute demyelin-
ation (acute CPZ, n = 12). After 6 weeks, all mice were
fed normal chow. The mice were then singly housed in
home cages with (naïve, n = 6, acute CPZ, n = 6), or
without (acute CPZ, n = 6), Miss-step wheels for 2
weeks. Mice were perfused for in situ hybridization.
Across the three conditions, cell densities were quanti-
fied from at least 3 sections per mouse and analyzed
using one-way ANOVA with Tukey’s multiple compari-
sons test.
Miss-step wheel analysis of iNSC transplantation on CC
function
Running on Miss-step wheels, with irregularly spaced
rungs, presented a novel motor skill task to evaluate ef-
fects of iNSC transplantation on sensorimotor function
during recovery after chronic CPZ. Cohorts were main-
tained under the same conditions for simultaneous auto-
mated data collection. The study included four cohorts
of 12 mice each, which included naïve with vehicle injec-
tion (n = 4), CPZ with vehicle injection (n = 4), and CPZ
with iNSC transplant (n = 4). Of the four cohorts run,
one cohort was excluded due to the CPZ vehicle condi-
tion failing to demonstrate a demyelination associated
deficit, compared to naïve. Data from 3 independent co-
horts of 12 mice each was combined for analysis of naïve
(n = 11), CPZ vehicle (n = 12), and CPZ iNSC (n = 11).
Death prior to the experimental endpoint required ex-
clusion of one mouse (CPZ iNSC, n = 1). A mouse
(naïve, n = 1) that did not achieve criterion (average vel-
ocity of 10 m/min by day 7) during the learning phase
was excluded from analysis of the plateau phase. A value
missing due to technical errors of the wheel system was
imputed based on the mean (n = 1 mouse on 1 d).
Velocity measures were compared using repeated mea-
sures two-way ANOVA with Sidak’s multiple compari-
son test. For in situ hybridization analysis in tissues from
mice with and without wheel exposure, additional mice
(naive veh, n = 5; CPZ veh, n = 5) were housed singly
without wheels in parallel with the wheel mice from two
different cohorts.
Tissue analysis of neuropathology and cellular responses
After completion of imaging or Miss-step wheel assess-
ments, mice were perfused for tissue analysis. Imaging
and wheel running cohorts were separately analyzed.
Quantification included at least 3 tissue sections per
mouse, unless otherwise noted. The number of mice for
each condition is provided with each experiment above
and is stated in each figure legend. Images for quantifi-
cation were acquired using an Olympus IX70 fluores-
cence microscope with a SPOT RT3 camera (Diagnostic
Instruments, Sterling Heights, MI). The CC ROI was de-
fined as extending from the midline bilaterally to the
point of ventral curvature in the external capsule [42,
47]. Coronal sections within − 0.5 and − 2.0 mm relative
to bregma were used for quantification, to focus in the
most demyelinated region and minimize variation [40].
Unpaired t-tests were used to compare two conditions,
i.e. naïve vs. CPZ, or veh vs. iNSCs. After the Miss-step
wheel running, further analysis of oligodendrocyte popu-
lations for CPZ veh vs. CPZ iNSCs used two-way
ANOVA with Sidak’s multiple comparisons test.
Immunohistochemistry
Mice were perfused transcardially with 4% PFA, post-
fixed overnight at 4 °C, and processed for frozen section-
ing. Coronal cryosections (15 μm) were immunostained
with primary antibodies to detect either myelin based on
myelin oligodendrocyte glycoprotein (MOG, mouse
monoclonal, 1:100; EMD Millipore, Burlington, MA;
mab5680, RRID:AB_1587278), astrocytes with GFAP
(rabbit polyclonal, 1:500; DAKO; Z0334, RRID:AB_
10013382), microglia/macrophage with IBA1 (rabbit
polyclonal, 1:500; Wako, Richmond, VA; 019–19,741,
RRID:AB_839504), oligodendrocyte lineage cells with
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Olig2 (rabbit polyclonal, 1:500; EMD Millipore, ab9610,
RRID:AB_570666), OPCs with NG2 (rabbit polyclonal to
ectodomain; generous gift from William Stallcup; RRID:
AB_2572306) and neural stem/progenitor cells with
Sox2 (rabbit polyclonal, 1:200; Abcam, ab97959, RRID:
AB_2341193). Cells undergoing active proliferation were
identified by Ki67 (rabbit polyclonal, 1:500; Abcam ab
15,580, RRID:AB_443209). Axons were identified by
neurofilament heavy chain protein (NF-H) rabbit poly-
clonal antibody (1:500; RPCA-NF-H Encor Biotechnol-
ogy, Gainesville, FL, RRID:AB_2572360) with the
proportion with axon damage immunolabeled for SMI32
mouse IgG1 monoclonal antibody, which recognizes
nonphosphorylated neurofilaments (1:1000; Sternberger
monoclonal SMI32; 801,701 Biolegend, San Diego, CA,
RRID:AB_2564642). The secondary antibodies used were
donkey anti-rabbit IgG F(ab’)2 (Jackson ImmunoRe-
search, West Grove, PA) conjugated with Cy3 (1:400 or
1:500; 711–166-152, RRID:AB_2313568) or AF647 (1:
100; 711–606-152, RRID:AB_2340625), donkey anti-
mouse IgG IgG F(ab’)2 conjugated with Cy3 (1:100; Jack-
son ImmunoResearch; 715–166-150, RRID:AB_
2340816), goat anti-rabbit IgG conjugated with AF647
(1:200; Thermo Fisher; A21245, RRID:AB_2535813) and
goat anti-mouse IgG conjugated with AF555 (1:500;
Thermo Fisher; A21422, RRID:AB_2535844). Nuclei in
all sections were counterstained with DAPI (Sigma-Al-
drich). The GFP expression of iNSCs was sufficient for
direct detection without using additional antibody
detection.
In situ hybridization
In situ hybridization using a proteolipid protein (Plp1)
riboprobe was performed as previously described [55,
56]. The Enpp6 plasmid vector (pCMV-SPORT6, gift
from Dr. William D. Richardson, University College
London) was used to generate the Enpp6 riboprobe
(Xiao et al. 2016 [57]). In 15 μm coronal cryosections,
hybridized Plp1 or Enpp6 riboprobe was detected with
alkaline phosphatase-conjugated sheep anti-digoxigenin
antibody and incubation in substrate solution (nitroblue
tetrazolium chloride/5–bromo-4–chloro-3–indolyl-phos-
phate [NBT/BCIP]; Dako).
Quantification details for CC area, myelin, astrogliosis and
microglia activation
Immunolabeling within the CC ROI was quantified on
images acquired with a 10x objective. Metamorph soft-
ware (RRID:SCR_002368; Molecular Devices, Downing-
ton, PA) was used to measure the total CC ROI area in
coronal sections immunolabeled for MOG along with
DAPI staining of nuclei for cytoarchitecture of CC as
distinct from adjacent regions. Myelination of the CC
was measured based on pixel intensity values to
determine the MOG immunolabeled pixels above back-
ground levels using the Metamorph thresholding func-
tion [20]. Similar thresholding was used to quantify
astrogliosis and microglia activation based on GFAP and
IBA1 immunoreactivity, respectively.
Quantification details for structure tensor analysis of
astrocytes and myelin
NIH ImageJ software (ImageJ, RRID:SCR_003070) with
the OrientationJ Plug-in (RRID:SCR_014796, http://
bigwww.epfl.ch/demo/orientation/) was used for struc-
ture tensor analysis [58]. Images were acquired with a
10x objective. Using the polygon tool, the ROI was se-
lected within the CC under the medial extension of the
cingulum. This CC region avoids the curvature toward
the midline and the crossing fibers that are present more
laterally. The program computes the microscopic, or
local, orientation and local coherence for each pixel. The
local orientation uses a color map to represent the direc-
tional distribution. The local coherence is a measure of
the alignment of anisotropic domain tensors. Both the
anisotropy of a local domain and the coherence of do-
mains within a voxel contribute to fractional anisotropy
[59].
Quantification details for oligodendrocyte lineage
populations
Oligodendrocyte counts in the CC were based on in situ
hybridization and quantified from bright field images
with the CC ROI area measured using Spot Advanced
Software (RRID: SCR_014313; Spot imaging solutions,
Sterling Heights, MI). Plp1low expressing cells had
mRNA transcripts localized mainly in the perinuclear
cytoplasm; in Plp1high expressing cells, darker substrate
reaction was evident in the cell body and extended out
into processes [20, 47, 60]. Only cells with strong sub-
strate reaction for Enpp6 transcript levels were counted
as specific labeling of newly formed oligodendrocytes
[57]. Quantification of proliferating OPCs in the CC and
cingulum were identified based on Ki67 immunoreactive
nuclei and NG2 immunolabeling of the cell body and
processes. Ki67 and NG2 analysis included only one sec-
tion per mouse due to the limited availability of tissue
within the defined coronal levels.
Quantification details for axon damage
Confocal images were acquired at 63x and quantified in
maximum intensity projections of the ROI (59.70 μm, y:
59.70 μm, z: 1.60 μm) in the cingulum. The ROI was posi-
tioned adjacent to the CC and centered under the peak of
the cingulum. Individual axons were manually counted as
immunolabeled for NF-H with or without co-labeling for
SMI32. Nuclei were counted simultaneously. Ipsilateral
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and contralateral sides were quantified in at least 3 sec-
tions per mouse.
Transplanted iNSC localization and differentiation in vivo
Transplanted iNSCs were quantified by direct
visualization of GFP expression using a 40x objective on
an Olympus IX-70 microscope. Tissue sections were ana-
lyzed from mice in the imaging (n = 6) and Miss-step
wheel assessments (n = 11) that were used for quantifica-
tion of MOG, GFAP, and IBA1 immunoreactivity. The in
situ hybridization reaction for Plp1 precluded identifica-
tion of GFP expression from iNSCs. Additional tissue sec-
tions were immunostained for labeling of iNSCs with cell
type markers. Overall, this iNSC cell type quantification
included at least 6 mice per cell type immunostain with at
least 3 sections analyzed per mouse combining to approxi-
mately 200 iNSCs each for Sox2 and for Olig2, with ap-
proximately 600 iNSCs counted for GFAP which included
sections from the neuropathology analysis of astrogliosis.
Transplanted iNSCs were analyzed in vivo only within
coronal sections from rostrocaudal levels matching the
neuropathology ROI (− 0.5 mm to − 2.0 mm from
bregma), which focused on the most demyelinated CC
region and minimize variation [40]. Regions of the cere-
bral cortex and cingulum above the CC, and hippocam-
pus below the CC, were quantified within the same
coronal sections as the CC. In total, 1585 iNSC cells
were counted from among mice combined from MRI
and Miss-step wheel cohorts and graphed to represent
the distribution within the tissue as white matter (CC,
cingulum) and adjacent gray matter (cortex, hippocam-
pus). Contingency tables were used to analyze in vivo
differentiation of iNSCs after transplantation with Fish-
er’s exact test for statistical significance.
Additional images of GFP cells were acquired on a
Zeiss 700 laser scanning confocal microscope (Carl
Zeiss, San Diego, California; RRID:SCR_017377) with in-
dividual laser lines sequentially collected for each chan-
nel using a Plan-Apochromat 63x/1.4 oil objective. An
optical image stack was acquired, and maximum inten-
sity projection images were generated from each image
stack with Zen software (Carl Zeiss, ZEN Digital Im-
aging for Light Microscopy, RRID:SCR_013672).
Results
Characterization of iNSC preparations used for
transplantation
Induced neural stem cells (iNSCs) have the potential to
self-renew and to differentiate along three neural lineages
[29, 31, 32, 51]. Following revival and expansion, iNSCs
were assessed for self-renewal as neurospheres (Fig. 1a-b)
and differentiation along neural lineages (Fig. 1c-e). In
vitro, iNSCs demonstrated immunolabeling for neural
stem/progenitor cell markers, Nestin and Sox2, and
neurosphere formation (Fig. 1a-b). iNSC self-renewal was
exhibited by log phase cell amplification after each passage
(Fig. 1f). Following growth in differentiation media,
iNSCs acquired markers for either astroglial (GFAP,
Fig. 1c), neuronal (MAP2, Fig. 1d), or oligodendroglial
(O4, Fig. 1e) lineages. Differentiation was confirmed
for each aliquot of iNSCs used for transplantation ex-
periments (Fig. 1g).
Longitudinal MRI technique evaluation with post-imaging
validation of chronic CPZ pathology
Prior to studies of iNSC transplantation, we first tested
the set of MRI techniques for quantification of the pro-
gression of CPZ acute and chronic demyelination (Fig. 2).
These techniques quantitatively demonstrate MRI changes
in the CC at 6 and 12weeks after CPZ in comparison with
naïve mice fed normal chow across the same time course
(Fig. 2a). The T2 and direction-encoded color images
show that acute and chronic CPZ changes are most
marked in the medial CC (Fig. 2b). CPZ increased the T2-
weighted signal, which reflects increased unbound water,
while reducing the magnetization transfer ratio (MTR) as-
sociated with water bound to membranes, including mye-
lin (Fig. 2c-d). Diffusion tensor imaging (DTI) values
provided complementary measures (Fig. 2e-h). Trace
values indicated increased water diffusion within the CC
after CPZ. Reduced fractional anisotropy (FA) was driven
by increased radial diffusivity (RD), which can be associ-
ated with demyelination. Axial diffusivity (AD) was not al-
tered after 6 or 12 weeks of CPZ, which is in agreement
with our prior studies that found axonal beading and al-
tered AD at 3–4 weeks of CPZ was attenuated by the 6
week time point [40, 41, 61, 62].
Post-imaging neuropathology focused on CC myelin-
ation and neuroinflammation to characterize the chronic
lesion environment into which iNSCs would be trans-
planted in subsequent experiments (Fig. 3). Mice from
the MRI cohort were perfused after the final scan.
Chronic CPZ mice had significant CC atrophy, based on
the reduced area measured, and significant demyelin-
ation demonstrated with immunolabeling of myelin.
Chronic CPZ also resulted in persistent astrogliosis,
which is a feature of sclerotic lesions. Increased micro-
glial signal also indicated CC neuroinflammation.
Longitudinal MRI and post-imaging neuropathology
changes after iNSC transplantation during chronic
demyelination
Longitudinal MRI scans of each mouse at multiple time
points were used to demonstrate the progression of CPZ
pathology before, and then after, iNSC or vehicle injec-
tion (Fig. 4a). Representative T2 and direction-encoded
color images illustrate baseline, i.e. before initiating CPZ,
for comparison with the final scan after CPZ and either
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vehicle or iNSC injection (Fig. 4b). Robust reproducibil-
ity is indicated by the similar changes observed from
baseline to 6 and 12 week CPZ time points in this cohort
(Fig. 4c-h) relative to naïve mice and baseline vs. 6 and
12 week CPZ time points in the validation cohort (Fig.
2c-h). At 12 weeks of CPZ, values are increased for T2,
Trace and RD; CPZ decreased MTR and FA, while AD
was not changed at 12 weeks (Fig. 4c-h). After removal
of CPZ and return to normal chow, mice received iNSC
or vehicle injection into the CC. Notably, the iNSC
transplants resulted in significant recovery of DTI RD
values (Fig. 4h), suggesting an iNSC effect on CC micro-
strucuture that did not significantly change the other
imaging parameters (Fig. 4c-g).
Post-imaging neuropathology focused on CC myelin-
ation and neuroinflammation, with additional analysis of
the endogenous oligodendrocyte population after iNSC
transplantation (Fig. 5). Mice that received iNSCs did not
exhibit overt changes in CC myelination, as compared to
vehicle-injected mice (Fig. 5a-b). Transplanted iNSCs were
found in the CC and the overlying white matter of the cin-
gulum, and in adjacent gray matter of the adjacent cortex
and hippocampus (Fig. 5c). The iNSCs exhibited mainly
rounded morphologies, while some cells had extended
processes (Fig. 5d). To determine whether transplanted
iNSCs elicited a response among endogenous CC cells,
sections were examined using immunolabeling for GFAP
for astrocytes (Fig. 5c-d), IBA1 for microglia (Fig. 5e), and
Fig. 1 Mouse induced neural stem cells (iNSCs) exhibit stem cell characteristics in vitro. a-b: In vitro, iNSCs form neurospheres (a) and express
NSC markers Sox2 (red) and Nestin (pseudocolored green). c-e: Following differentiation of iNSCs, constitutively expressed green fluorescent
protein (GFP) is visible in all cells (c) while cells differentiated along an astrocytic lineage exhibit immunolabeling for GFAP (red, c). In addition,
differentiation along neuronal (MAP2; red, d) and oligodendroglial (O4; red, e) lineages shows multipotency of iNSCs (GFP not shown). f: In non-
differentiation conditions, iNSCs exhibit an exponential proliferation rate expected for stem cell growth based on quantification of each
subculture after each passage. g: Quantification of iNSC multipotent differentiation from separately revived vials (n = 4). Data are mean values ±
sem. Scale bar A = 100 μm, B, D, E = 20 μm, C = 40 μm
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in situ hybridization to detect oligodendrocyte expression
of Plp1 (Fig. 5f). The findings of CC atrophy and demye-
lination at 12 weeks of CPZ (Fig. 3g-h) persisted at similar
levels after the 2-week recovery period on normal chow,
and were not attenuated by iNSC transplantation (Fig. 5g-
h). Interestingly, astrogliosis persisted in vehicle-injected
Fig. 2 MRI techniques detect progression of corpus callosum (CC) pathology during acute through chronic cuprizone (CPZ). a: Experimental
timeline for longitudinal in vivo magnetic resonance imaging (MRI) of the same mice scanned three times: at baseline (BL, 8 weeks of age prior to
the start of CPZ), again after acute CPZ (6 weeks) and finally after chronic CPZ (12 weeks). Naïve mice were scanned at matched time points but
continuously fed normal chow pellets without CPZ. CC region-of-interest (ROI) for quantification shown in yellow with DAPI nuclear staining of
cytoarchitecture. b: Representative T2-weighted images with corresponding direction encoded (DEC) color images below for each set. T2 panels
show increased signal intensity in the CC during acute and chronic CPZ while DEC maps show altered CC microstructure, as compared to naïve
mice (age-matched to the 12 week CPZ time point). Arrows indicate medial CC regions that show CPZ effect. Colors represent fiber directions as
red (medial-lateral), blue (anterior-posterior), and green (superior-inferior). c-h: Quantitative analysis of the CC shows significant differences
between naïve and CPZ mice at both 6 weeks and 12 weeks after the start of CPZ using values from T2-weighted imaging (c), magnetization
transfer ratio (MTR, d), and diffusion tensor imaging parameters of trace (e), fractional anisotropy (FA; f), and radial diffusivity (RD; h). Axial
diffusivity (AD, g) remained unchanged. Bar color reflects the treatment condition. The naïve cohort (white; no cuprizone shown as “-“under bars)
was scanned along with the CPZ cohort at each of the three time points. The CPZ cohort was scanned at baseline (gray; “-“before starting CPZ)
and during demyelination (black; at 6 and 12 weeks of CPZ). Data are mean values ± sem. Two-way ANOVA with repeated measures and
Bonferroni multiple comparisons test for naïve (n = 6) versus CPZ (n = 6) mice
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mice and was significantly reduced with iNSC transplant-
ation (Fig. 5i). The microglial immunoreactivity did not
show an effect of iNSC transplantation (Fig. 5j). The oligo-
dendrocyte population appeared only slightly increased
after iNSC transplantation, and did not reach a statistically
significant effect (Fig. 5k).
The astrogliosis is a remarkable feature of this chronic
demyelination model (Figs. 3c-d, 5c-d). Given the high
astrocyte density and aligned orientation, we examined
the structure tensor characteristics of CC immunolabeled
astrocytes after chronic CPZ (Fig. 6). Structure tensor ana-
lysis applied to histological tissue can quantify micro-
scopic features that add to the interpretation of tissue
microstructure, and has been used for analysis of myelin
immunolabeling in chronic CPZ [58, 59, 63]. The images
used to quantify GFAP immunoreactivity post-MRI (Figs.
3i, 5i) were used for structure tensor analysis. In naïve
mice, GFAP immunolabeled cells had a relatively isotropic
appearance (Fig. 6a). After chronic CPZ, the GFAP immu-
nolabeled cells exhibited coherence of local domains for
Fig. 3 Post-MRI pathology after chronic CPZ. a-f: Coronal sections from naïve and 12 wk. CPZ perfused after final MRI (Fig. 2) and immunolabeled
for either myelin (MOG; a-b), astrocytes (GFAP; c-d), or microglia (IBA1; e-f), along with DAPI nuclear stain (blue; c-f). g-j: Quantification of
immunolabeling in this post-MRI cohort shows that chronic CPZ results in significant CC atrophy (g) with demyelination (h), astrogliosis (i), and
microglial activation (j). CC area was measured using DAPI nuclear staining of cytoarchitecture and MOG immunoreactivity. Bar color reflects
condition as naïve (white; no cuprizone), or demyelinated (black; 12 weeks of cuprizone). Data are mean values ± sem. Naïve (n = 6) compared to
chronic CPZ (n = 6) using t-tests. Scale bars A, B: shown in A = 200 μm; C, D: shown in C = 100 μm; E, F: shown in E = 100 μm
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effective anisotropy (Fig. 6b). In naïve mice, astrocyte pro-
cesses extended in many directions, as indicated by varied
color encoding of the orientation (Fig. 6c). After CPZ, re-
active astrocytes were highly oriented in parallel to the
axis of axons, as indicated by the mainly green encoded
orientation in the CC but magenta in the perpendicularly
oriented cingulum tract (Fig. 6d). Microscopic, or local,
GFAP coherence was significantly increased within the
CC after 12 weeks of CPZ compared to naïve mice (Fig.
6e). Surprisingly, the GFAP coherence level was as high as
that measured for MOG immunolabeling of myelin (Fig.
6f, g). Myelin and axons are considered major components
influencing diffusion tensor imaging values, although cell
density and edema are also important factors [64]. These
results raise the possibility that astrogliosis can signifi-
cantly contribute to microstructure signal, which may be
relevant for sclerotic MS lesions. Reduced overall GFAP
immunolabeling after iNSC transplantation (Fig. 5i) may
Fig. 4 MRI radial diffusivity indicates reduced CC pathology with iNSC transplantation. a: Experimental timeline for longitudinal imaging of mice
across 4 time points: baseline (BL) before initiating CPZ, at 6 weeks of CPZ, and at 12 weeks of CPZ before and finally at 2 weeks after iNSC, or
vehicle, injection. After the scan at 6 weeks of CPZ, mice were randomized to vehicle or iNSC injection. After 12 weeks of CPZ, mice were
returned to normal chow pellets for 1 day before intracerebral injection. CC region-of-interest (ROI) for quantification shown in yellow with iNSC
injection path shown in green, with DAPI nuclear staining of cytoarchitecture. b: Representative T2-weighted and DEC images. Arrows indicate
medial CC regions that show CPZ effect. Colors reflect fiber directions as red (medial-lateral), blue (anterior-posterior), and green (superior-inferior).
c-h: Quantitative analysis of the CC shows significant differences from baseline result from CPZ administration using values from T2-weighted
imaging (c), MTR (d), trace (e), FA (f), and RD (h). The AD values only differ from baseline at the 14 week time point (g). The comparison of iNSC
transplantation versus vehicle (Veh) shows a significant effect in RD values (h, green bracket). Horizontal line shown extends from the baseline
value of the cohort that later received iNSCs after 12 weeks of CPZ. Bar color reflects condition as baseline (gray fill), demyelinated with CPZ
(black fill) or iNSC transplant after chronic CPZ (green fill). Borders around bars denote same mice that received iNSC (green border) or vehicle
(black border) after ending cuprizone. Data are mean values ± sem. Two-way ANOVA with repeated measures and Bonferroni multiple
comparisons test for CPZ with injection of vehicle (n = 5) versus iNSCs (n = 6)
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reduce the overall anisotropic contribution of reactive as-
trocytes among all the cellular structures contributing to
the DTI FA. The DTI AD component of FA is strongly
driven by axons [61], and was not significantly different
after iNSC transplantation (Fig. 4g). Conversely, the DTI
RD component can be driven by myelin changes [61]. Our
data suggest that the reduced DTI RD after iNSC trans-
plantation (Fig. 4h) may possibly be influenced by changes
in reactive astrogliosis after chronic CPZ, since GFAP and
MOG immunoreactivity exhibited similar coherence (Fig.
6f-g). However, our 2-dimensional pixel scale structure
tensor analysis can reveal local microstructure features
but cannot demonstrate specific correlation to the much
larger 3-dimensional DTI voxel scale features.
Reduced neurologic impairment after iNSC
transplantation during chronic demyelination
We next tested whether iNSC transplantation could re-
duce neurologic functional deficits after chronic CPZ
(Fig. 7). Running on Miss-step wheels, with irregularly
Fig. 5 Post-MRI pathology shows iNSC reduction of astrogliosis. a-e: Coronal sections from chronic CPZ mice with vehicle (Veh) or iNSC injection
immunolabeled to detect myelin (MOG; a-b), or the innate immune response of astrocytes (GFAP; c-d) or microglia (IBA1; e) with DAPI nuclear
stain (blue; c-e). Panel C shows an example of transplanted iNSCs (green, GFP) in the CC and adjacent white matter (cingulum; Cg) and gray
matter regions (cortex, Cx; hippocampus, Hp). Panel D shows higher magnification of iNSCs (green, GFP) in the CC with examples of round cells
(white arrows) and elongated cells with extended processes (yellow arrow). Panel E shows IBA1 immunolabeling of microglia (red) with lipofuscin
granules (yellow autofluorescence) that accumulate after chronic CPZ. f: Coronal CC sections processed for in situ hybridization to detect
oligodendrocytes expressing proteolipid protein (Plp1). g-k: Quantification of tissue analysis in this post-MRI cohort shows CC atrophy and
demyelination are not attenuated by iNSCs (g, h). Transplanted iNSCs reduced astrogliosis (i), but did not change the microglial (j) or
oligodendrocyte response (k). Bar color reflects condition as chronic cuprizone followed by vehicle injection (black) or iNSC transplant (green).
Data are mean values ± sem. Vehicle (n = 5) and iNSC (n = 6 IHC, n = 5 Plp1) conditions were compared using t-tests. Scale bars: A, B shown in
A = 200 μm; C = 200 μm; D = 20 μm; E = 100 μm; F = 40 μm
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spaced rungs, was used because this assessment is sensi-
tive to deficits associated with CPZ demyelination and
targeted to CC function [33, 57]. After 12 weeks of CPZ,
mice were returned to normal chow and then received
iNSC or vehicle injections followed by exposure to Miss-
step wheels for 2 weeks (Fig. 7a). Age matched naïve
mice received vehicle injections and were maintained
within the CPZ cohorts. Comparison of vehicle-injected
controls showed significant deficits between naïve and
chronic CPZ, which were evident in both the average
daily running velocity (Fig. 7b) and the maximal daily
running velocity (Fig. 7c). Chronic CPZ impaired motor
skill learning (learning phase) with significant perform-
ance deficits (plateau phase). On the contrary, mice with
iNSC transplantation did not have significant deficits in
either the average or maximum running velocities after
Fig. 6 Astrogliosis of chronic CPZ increases coherence within CC. a-b: Coronal sections from naïve and 12 week CPZ mice perfused after final MRI
and immunolabeled for GFAP to detect astrocytes. Coherence of astrocyte morphology was measured in a CC area (yellow rectangle) of relatively
aligned anatomical structure. In the non-pathological CC of naïve mice, the astrocyte density is low and cell processes extend in many directions,
resulting in close to isotropic coherence (a; red). After CPZ, astrocytes have a high density and align parallel to axons in the chronically
demyelinated CC, so that the GFAP immunoreactivity exhibits anisotropic coherence (b, red). c-d: Color maps illustrating the orientation (c, inset)
of the astrocyte cell bodies and processes in higher magnification images taken from the same sections as in A and B. In naïve mice, astrocyte
cell bodies and processes exhibit diverse color encoding indicating orientation in many directions (c). After CPZ, astrocytes are aligned parallel to
axons in the CC (green color orientation) and in the perpendicularly aligned cingulum (Cg) tract (magenta color orientation). e-g: Quantification
of the coherence shows a significant increase in CPZ demyelinated mice (e) that does not recover during the 2 weeks on normal chow (f), and is
not changed in iNSC transplant mice (f). In sections immunolabeled for MOG (g), the coherence for myelin is similar to that measured for
astrocytes (f-g). Bar color reflects condition as chronic cuprizone followed by vehicle injection (black) or iNSC transplant (green). Data are mean
values ± sem. Mouse numbers shown in Figs. 3 and 5, with comparison by t-test. Scale bars A, B shown in A = 100 μm; C, D shown in C = 100 μm
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Fig. 7 Recovery of motor function with iNSC transplantation. a: Experimental timeline for functional assessment after iNSC (or vehicle) injection.
After 12 weeks of CPZ, mice were returned to normal chow with intracerebral injection performed the following day and exposure to Miss-step
wheels the next day. Miss-step wheels with irregularly spaced rungs present a motor skill task mice must learn to run rapidly (week 1); the
subsequent plateau velocity reveals deficits of bilateral sensorimotor function (week 2). b-c: The average velocities (b) and the maximum
velocities (c) show deficits in vehicle-injected CPZ mice during the learning phase that reach statistical significance during the plateau phase, as
compared to naïve mice. CPZ mice injected with iNSCs show recovery in that both average and maximum velocities are not significantly
different from the naïve mice. Velocity measures were compared using two-way ANOVA with Sidak’s multiple comparison test. Data are mean
values ± sem. Data from 3 independent cohorts was combined for analysis of naïve (n = 11), CPZ vehicle (n = 12), and CPZ iNSC (n = 11)
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chronic demyelination, compared to naïve mice (Fig. 7b-
c), suggesting improved motor learning and
performance.
Increased oligodendrocyte response to iNSC
transplantation during chronic demyelination
Following behavior testing, the same mice were analyzed
for neuropathology and the oligodendrocyte response to
iNSC transplantation (Fig. 8). Overtly, CC atrophy and
myelination appeared similar in vehicle injected com-
pared to iNSC transplant mice (Fig. 8a-b). Transplanted
iNSCs were observed along the track of the injection, in
the CC, cingulum, and adjacent cortex, and rarely in the
underlying hippocampus (Fig. 8c). Astrogliosis persisted
in the CC after iNSC transplantation and exposure to
Miss-step wheels (Fig. 8c). The iNSCs did not express
the microglial marker IBA1 and did not markedly alter
lipofuscin granules in microglia, which were evident
after chronic CPZ with and without iNSC transplant-
ation (Fig. 8d). The oligodendrocyte populations, de-
tected by Plp1 expression, appeared to vary in both
density and morphology (Fig. 8e-f). Note that the in situ
hybridization technique for Plp1 transcripts is not com-
patible with immunofluorescence detection of GFP ex-
pression to identify iNSCs in these images. Based on
quantitative analyses, iNSC transplantation did not at-
tenuate CC atrophy (Fig. 8g), demyelination (Fig. 8h), or
astrogliosis (Fig. 8i), compared to vehicle injection.
Microglia immunoreactivity was relatively low after the
recovery period in both iNSC and vehicle mice (Fig. 8j).
Importantly, iNSC transplantation significantly increased
the oligodendrocyte cell density compared to vehicle in-
jection (Fig. 8k).
Given the iNSC effect on Plp1, we focused on its ex-
pression during the recovery period after chronic CPZ,
which appeared to vary in both density and morphology
(Fig. 8e, f). Plp1 transcripts were noted mainly in the peri-
nuclear cytoplasm of low expressing oligodendrocytes, but
also extended out into processes of oligodendrocytes ex-
pressing high levels of Plp1 (Fig. 8f). This observation was
supported by several aspects of Plp1 expression indicating
potential interest as a dynamic response during remyelina-
tion. An increase of Plp1 expressing cells has long been
associated with remyelination in MS lesions [65]. Plp1 ex-
pression can be regulated by interaction with axons during
development [66]. In neonatal rat cultures, Plp1 tran-
scripts are initially localized in oligodendrocyte peri-
nuclear cytoplasm then are also present in primary
processes after a delay of several days [67]. In adult mouse
white matter, Plp1 transcripts are typically localized in
oligodendrocyte cell bodies [68].
Additional analysis explored the effect of iNSC trans-
plantation on the Plp1 expressing oligodendrocyte popu-
lations. Oligodendrocytes were distinguished based on
Plp1 expression as Plp1low with perinuclear transcript
localization, or Plp1high with more intense signal in the
cell body and extending into processes (Figs. 8e-f and 9).
Among the wheel running mice, iNSC transplantion sig-
nificantly increased Plp1low cells, compared to vehicle
injected mice (Fig. 9a). After chronic CPZ, OPCs and
Ki-67 labeled proliferating cells are relatively rare as
compared to the robust proliferation and amplification
of OPCs after acute CPZ [20]. However, transplantation
of iNSCs increased the frequency of proliferating OPCs
during remyelination with wheel access (Fig. 9b-c).
Additional studies were conducted to gain insights as to
the Plp1low and Plp1high populations relative to demyelin-
ation and remyelination, additional mice were analyzed
without wheel exposure (Fig. 9d-i). In the absence of
wheel exposure, Plp1low cells comprised the majority of ol-
igodendrocytes in naïve mice and were significantly re-
duced after chronic CPZ (Fig. 9d). In contrast, chronic
CPZ increased the Plp1high population, suggesting an up-
regulation of Plp1 transcription consistent with early
remyelination (9E). Newly formed oligodendrocytes can
be identified by high expression of Enpp6 transcripts dur-
ing learning in healthy adult mice [57]. The effect of wheel
access on Plp1 and Enpp6 oligodendrocyte populations
was examined using acute CPZ demyelination for more
extensive remyelination (Fig. 9f-h). Acute CPZ reduced
Plp1low cells and increased both Plp1high and Enpp6high
cells. Wheel access during remyelination simultaneously
decreased Enpp6high cells and increased Plp1low cells.
These findings can be modeled as stages of maturation
during remyelination (Fig. 9i) and suggest that wheel ex-
posure advances maturation to the Plp1low phenotype.
Together, these results indicate that iNSC transplant-
ation in combination with motor skill learning on Miss-
step wheels enhanced the generation of endogenous pro-
liferating OPCs and their differentiation into mature
oligodendrocytes.
iNSC differentiation along oligodendrocyte and astrocyte
lineages exhibits interaction with host brain after
transplantation into chronic lesions
iNSC location and differentiation were analyzed in mice
combined from the MRI and behavior cohorts (Fig. 10).
Transplanted iNSCs were located primarily in white
matter of the CC or adjacent cingulum (Fig. 10a). A sub-
population of iNSCs maintained expression of Sox2
(Fig. 10b), a neural stem/progenitor cell marker [69, 70].
iNSCs differentiated along the oligodendrocyte lineage,
as identified by Olig2 (Fig. 10c), and the astrocyte
lineage, as identified by GFAP (Fig. 10d). In the white
matter, iNSC differentiation was not significantly differ-
ent between MRI and wheel cohorts for Olig2 (MRI
24.4%; wheels 24.4%; p = 0.8547) or for GFAP (MRI
21.2%; wheels 15.6%; p = 0.1673). iNSCs were also found
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in gray matter regions near the needle injection track
(Fig. 10a-d). The tissue environment had a marked effect
on the iNSC astroglial and oligodendroglial fate of trans-
planted iNSCs (Fig. 10c-d). iNSC differentiation into
oligodendrocyte lineage cells was 31.1% O4 cells in vitro
(Fig. 1d) and 25.6% Olig2 in white matter but increased
significantly to 42.4% in gray matter (Fig. 10c). iNSC dif-
ferentiation into astrocytes was 57.3% under in vitro
Fig. 8 Post-behavior analysis of CC remyelination and endogenous glial cell response. a-b: Coronal CC sections immunolabeled for MOG to
detect myelin in the wheel cohort mice after chronic CPZ with vehicle (a) or iNSC (b) injections. c-d: Innate immune cell response examined with
immunolabeling for GFAP (c) or (d). Panel C shows astrogliosis and transplanted iNSCs (green, GFP) within the CC and adjacent areas in a section
containing the region of the injection needle track. Panel D shows higher magnification of an iNSC (green, GFP; white arrow) in the CC with thin
processes. IBA1 immunolabeled cells contain lipofuscin granules (yellow autofluorescence; yellow arrows). iNSCs did not immunolabel for IBA1. e-
f: Coronal CC sections processed for in situ hybridization to detect oligodendrocytes expressing proteolipid protein (Plp1). Plp1 appears
upregulated after iNSCs transplantation (f) compared to vehicle (e). Plp1 transcripts are localized in the cell body in most cells while a subset of
cells show more intense labeling in the cell body and extending into processes. g-k: Quantification of tissue analysis in this post-behavior cohort.
CC atrophy and demyelination are not attenuated by iNSCs (g, h). Transplanted iNSCs did not reduce astrogliosis (i) or the microglial response (j).
In contrast, the iNSCs increased the oligodendrocyte population (k). Bar color reflects condition as chronic cuprizone followed by vehicle injection
and wheels (blue) or iNSC transplant and wheels (green). Data are mean values ± sem. Statistical analysis used t-tests to compare vehicle and
iNSC conditions. For immunolabeling (MOG, GFAP, IBA1), vehicle n = 12 and iNSC n = 11. For Plp1 in situ hybridization, vehicle n = 10, iNSC n = 9.
Scale bars: A, B, shown in A = 200 μm; C = 100 μm; D = 20 μm; E, F, shown in E = 50 μm
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conditions (Fig. 1g). Surprisingly, astrogliogenesis from
transplanted iNSCs was reduced to 36.8% in gray matter
and significantly decreased to 17.5% in white matter
after chronic CPZ (Fig. 10d). Immunolabeling for Ki67
detected iNSC proliferation only in a neurosphere
formed within the lateral ventricle under the CC in one
mouse (data not shown).
The membrane-targeted GFP revealed iNSC process
extension, indicating integration within the host tissue
(Fig. 10e-g). Process bearing iNSCs were co-labeled for
GFP along with Sox2 (Fig. 10e), Olig2 (Fig. 10f), or
GFAP (Fig. 10g) cell type markers, but were not immu-
nolabeled for IBA1 (data not shown). iNSCs were found
expressing the neural stem/progenitor marker Nestin,
which was not used for quantification due to immunola-
beling of extensive processes of reactive astrocytes after
chronic CPZ (data not shown), consistent with expres-
sion in astrocytes in reactive conditions [71]. Olig2 co-
labeled iNSCs in the CC extended GFP-labeled mem-
branes parallel to axons but did not clearly form myelin
internodes (Fig. 10f), in contrast to our prior studies il-
lustrating GFP labeling of newly formed myelin in
NG2CreERT;mTmG mice [72]. In gray matter, GFP-
labeled membranes appeared to form astroglial end
feet along blood vessels (Fig. 10g).
Axon damage after iNSC transplantation during chronic
demyelination
Mice from wheel running studies were further analyzed
to determine whether iNSC transplantation altered the
extent of axon damage after chronic CPZ (Fig. 11).
Axons were quantified in the cingulum which was
demyelinated after chronic CPZ (Fig. 3a-b) and con-
tained transplanted iNSCs (Fig. 10a). As compared to
the CC, cingulum axons have the advantages of being
distinct populations in each hemisphere that can be
quantified in transverse orientation which facilitates
quantification in the coronal tissue sections. Neurofila-
ment immunostaining of the overall axon populations
showed a slight reduction in the CPZ mice which was
Fig. 9 Transplantation of iNSCs alters oligodendrocyte populations during recovery. a: Tissues from the cohorts with Miss-step wheel access
(Figs. 7 and 8) were further analyzed based on Plp1 transcripts as either low, perinuclear signal (Plp1low) or high and extending into processes
(Plp1high). iNSC transplantation increased Plp1low cells during remyelination with wheel running access. b-c: Nuclear Ki67 identified rare
proliferating cells. iNSC transplantation increased the proportion of Ki67 cells immunolabeled for the NG2, a marker of OPCs, in the corpus
callosum ipsilateral (ipsi) to iNSC/vehicle injections (b). Example of a pair of proliferating OPCs (c, arrows) co-labeled for NG2 and nuclear Ki67
(overlap appears yellow) and quiescent OPCs (c, arrowheads). d-e: Analysis of additional mice without wheel access shows reduced Plp1low cells
(d) and increased Plp1high cells (e) during remyelination after chronic CPZ. This difference indicates that Plp1low and Plp1high cells represent distinct
lineage stages and/or responses after chronic CPZ. f-h: Cohorts using acute CPZ demyelination to induce extensive remyelination with and
without wheel exposure. Without wheels, CPZ decreased Plp1low cells (f) while increasing Plp1high cells (g) as well as newly forming
oligodendrocytes identified high expression of Enpp6 (Enpp6high) (h). Miss-step wheel access during remyelination simultaneously reduced
Enpp6high cells and increased Plp1low cells (f, h). i: Model integrating expression of Plp1 and Enpp6 transcripts during remyelination after acute and
chronic CPZ with iNSC and wheel effects. For oligodendrocyte graphs, bar color reflects condition: no cuprizone (white), cuprizone without
wheels (black), cuprizone with wheels (blue), and mice with iNSC (green). Data are mean values ± sem. For chronic CPZ mice from the wheel
running cohort, two-way ANOVA was used with Sidak’s multiple comparisons test of CPZ vehicle (n = 10) versus CPZ iNSC (n = 9). Ki67 and NG2
data analyzed using a contingency table with Fisher’s exact test for CPZ vehicle (n = 3) versus CPZ iNSC (n = 3). Chronic CPZ mice without wheel
exposure had naïve (n = 5) and CPZ (n = 5) conditions compared by t-tests. The acute CPZ study compared conditions of naïve (n = 6; n = 5 for
Enpp6) and CPZ (n = 6) mice with wheel exposure and CPZ (n = 6) mice without wheels using one way ANOVA with Sidak’s multiple
comparisons test
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not significant (Fig. 11a). Co-immunolabeling of non-
phosphorylated neurofilaments with SMI32 identifies
damaged axons after chronic CPZ [41]. Naïve and CPZ
mice with vehicle injections show that the injection pro-
cedure did not alter axons on the ipsilateral side
(Fig. 11a-b). The proportion of damaged axons is signifi-
cantly increased after CPZ in mice injected with vehicle,
but not in mice with iNSC transplants (Fig. 11b). Nu-
clear labeling with DAPI, as an estimate of changes in
cellularity, was increased after CPZ in mice receiving ve-
hicle or iNSC transplantation (Fig. 11c). Similar to find-
ings for the CC (Fig. 9b-c), rare proliferating cells
identified by Ki67 showed a significant increase in OPCs
immunolabeled for NG2 (Fig. 11d). Together, these find-
ings indicate that exogenous iNSCs modulate multiple
processes during remyelination.
Discussion
This study evaluated the potential for transplantation of
iNSCs to enhance recovery at a chronic stage of demye-
lination. MRI and neurological outcome measures
clearly demonstrated structural and functional deficits
from CPZ-mediated demyelination. MRI cohorts with
iNSCs showed reduced DTI RD, a parameter often asso-
ciated with aspects of remyelination after CPZ demyelin-
ation [61, 73]. Transplantation of iNSCs improved
running velocities during a Miss-step wheel task, which
is relevant to CC function [35].
Our study is the first to show improved performance
on a neurologic outcome measure following transplant-
ation of brain stem cells into the highly astrogliotic
demyelinated lesions produced by chronic CPZ.
Chronic CPZ model
The CPZ model is advantageous for testing cell-based
therapeutics after chronic demyelination. Oligodendro-
cyte loss from CPZ toxicity facilitates testing cell re-
placement from transplanted cells. CPZ pathology is
similar to MS lesions, specifically pattern III pathology
with oligodendrogliopathy and low lymphocyte infiltra-
tion [18, 74–76]. CPZ produces extensive astrogliosis
that persists through chronic demyelination [23]. In
addition to demyelination, CPZ results in axon damage
that forms varicosities from disrupted rapid axonal
Fig. 10 Transplanted iNSCs are localized mainly in white matter and express markers of oligodendrocyte and astrocyte differentiation. a: The
relative distribution of iNSCs in neuroanatomical regions adjacent to the CC target site. iNSCs quantified by direct detection of GFP expression in
tissue sections combined from analysis of mice in the MRI and behavior cohorts for neuropathology and iNSC cell type identification. b-d:
Quantification of differentiation of transplanted iNSCs in white matter based on direct visualization of GFP expression and co-labeling with
markers for neural stem/progenitor cells (Sox2), oligodendrocyte lineage cells (Olig2), or the astrocyte lineage (GFAP). Black fill shows counts of
iNSC co-labeled for given cell marker, with upper bar section showing unlabeled iNSC counts. Percent co-labeling shown for each region. e-g:
Examples of transplanted iNSCs expressing green fluorescent protein (GFP) along with nuclear Sox2 (e), nuclear Olig2 (f), or cytoplasmic GFAP (g).
iNSC membranes labeled for GFP extend around cell bodies (pink arrows), along axons (white arrow), and to blood vessels (blue arrow). iNSCs
were not identified as microglia in any sections analyzed with IBA1 immunolabeling. Microglia often contained autofluorescent lipofuscin
granules (f, yellow arrows). Tissue sections from mice of both the MRI (n = 6) and behavior (n = 11) cohorts were combined for the analysis of
iNSC distribution. Differentiation studies included a subset of mice (Sox2 (n = 6), Olig2 (n = 9), and GFAP (n = 14)) combined from MRI and
behavior cohorts to generate contingency tables of total cell counts among sections analyzed for comparison using Fisher’s exact test. Scale bars
E = 10 μm; F = 20 μm; G = 5 μm
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transport during the acute stage that progresses to neu-
rofilament dephosporylation and reduced axon diame-
ters after chronic CPZ [40, 41]. In patients with MS, CC
atrophy correlates with functional outcomes [25, 26].
Chronic CPZ exhibits CC atrophy, without decreasing
neurons in the cerebral cortex [24]. However, in the
current experiments, transplantation of iNSCs improved
function along with a moderate benefit on the oligo-
dendrocyte lineage response and axon damage, while not
reducing overall CC demyelination or atrophy.
Neuroimaging
MRI distinguishes CPZ disease stages with predominant
axon damage, demyelination, or remyelination [40, 77,
78]. DTI and other measures of CC integrity correlate
with functional measures in MS patients [79]. Decreased
DTI AD during acute CPZ (4 weeks) corresponds with
axonal varicosities and increased cellularity, but is less
effected with longer CPZ administration [40, 63]. DTI
RD increased during CPZ demyelination, and decreased
with improved remyelination in mice with genetic dele-
tion of Fgf2 or with estrogen receptor β ligand treatment
[41, 63]. The current longitudinal studies complemented
DTI with quantitative T2 and MTR. Our results agree
with reports of increased DTI RD and T2 values along
with decreased MTR during CPZ demyelination [40, 73].
Furthermore, mice with transplanted iNSCs had reduced
DTI RD during remyelination. Although the only MRI
parameter exhibiting a significant change from iNSC
transplant, this difference in DTI RD has robust statis-
tical power (96.3%) and effect size (Cohen’s d = 3.74).
Post-imaging pathology did not detect a difference in
overall CC remyelination within this MRI cohort. DTI
can be influenced by cellularity or edema [64]. There-
fore, iNSC effects on DTI RD may involve the reduced
astrogliosis, which can contribute to local anisotropy.
However, subtle changes to axon-myelin structure could
also be involved yet not detected by our post-imaging
analysis techniques. For example, T2 and DTI revealed
abnormalities in CST-KO mice that have detached mye-
lin at paranodes, without overt demyelination [80].
Functional outcome measure
After chronic CPZ iNSC transplantation promoted re-
covery as detected using the Miss-step wheel running
task. Miss-step wheels have a non-uniform pattern of
missing rungs. Mice learn to avoid stepping faults by
placing a hind paw onto a rung previously grasped by a
Fig. 11 iNSC transplantation modulates axon damage and cycling OPCs after CPZ chronic demyelination in the cingulum. a-b: Tissues from mice
with Miss-step wheel access during remyelination were further analyzed for axon damage in the cingulum to quantify the separate axon
population in each hemisphere relative to vehicle and iNSC injections. Axon damage was detected by immunolabeling of total axons with
neurofilament-H (a) and damaged axons with SMI32 for nonphosphorylated neurofilaments (b). Axon damage was increased significantly in
chronic CPZ mice injected with vehicle while iNSC transplantation slightly improved axon health toward naïve values (b). c: Chronic CPZ
increased overall cellularity in the cingulum, which was not altered by iNSC transplantation. d: Proliferating cells, identified by Ki67, were rare after
chronic CPZ but increased with iNSC transplantation, which was largely due to an increase of NG2 immunolabeled OPCs in the ipsilateral (ipsi)
cingulum. e-g: Representative images of each condition for neurofilament-H (pseudocolored green) labeled axons with SMI32 (red) co-labeling of
damaged axons and DAPI (blue) nuclear stain. Two-way ANOVA with Sidak’s multiple comparisons test for naïve (n = 6), CPZ vehicle (n = 6), and
CPZ iNSC (n = 6) comparison, and ipsi vs. contra comparison. Contingency table with Fisher’s exact test for comparison of Ki67 and NG2 in CPZ
vehicle (n = 3) and CPZ iNSC (n = 3) mice. Data are mean values ± sem, except for contingency analysis that shows total counts for each
condition. Scale bars E-G shown in E = 10 μm
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forepaw; learning this motor skill stimulates myelination
from CC oligodendrocyte lineage cells in healthy adult
mice [35]. The population of newly forming oligoden-
drocytes, expressing Enpp6, indicated interactive effects
of Miss-step wheels on endogenous cells during remyeli-
nation. Learning this skilled motor task may have con-
tributed to effects on oligodendrocyte differentiation,
since neuronal activity can modulate both new and
existing oligodendrocytes to contribute to remyelination
[81, 82]. After the learning phase, deficits in plateau run-
ning velocity correspond with myelination status [33,
35]. This Miss-step wheel running may also work as a
targeted exercise enrichment, acting in conjunction with
iNSC transplantation to promote recovery. For example,
normal running wheels acted in parallel with clemastine,
a pro-remyelinating treatment, to additively enhance
remyelination after lysolecithin demyelination [15].
Together, these findings suggest an intrinsic regenera-
tive potential for iNSC-based therapeutics and anticipate
further studies to examine the interaction between tar-
geted enrichment strategies and advanced regenerative
medicines that are targeted to improve function.
Host endogenous cell responses
The cohorts that exhibited improved function after iNSC
transplantation also had increased populations of host
endogenous oligodendrocytes. Transplantation of iNSCs
increased the total Plp1 expressing cells in the CC
among the mice that showed improvement of Miss-step
wheel running. The iNSC transplants significantly in-
creased the Plp1low population and may have transi-
tioned from the Plp1high population. The current results
are the first to show that both Plp1high and Enpp6high
cells increase during remyelination. Mice with iNSC
transplantation and wheel access also had an increased
proliferative response that was mainly comprised of
OPCs. Thus, iNSCs may act in conjunction with Miss-
step wheel running to promote differentiation of en-
dogenous OPCs into oligodendrocytes. This interpret-
ation is also in agreement with the slight increase of
Plp1 expressing cells after iNSC transplantation in the
MRI cohort.
Chronic CPZ produced persistent CC neuroinflamma-
tion, with astrogliosis being more marked than microglial
activation. Astrogliosis may mediate beneficial and detri-
mental effects on remyelination and axon degeneration in
the progression to chronic demyelination in CPZ and in
MS [23, 83, 84]. Astrogliosis was significantly reduced by
iNSC transplantation in the MRI cohort. However, this
GFAP reduction was not found in the wheel cohort.
Therefore, interpreting effects of iNSC transplantation
and/or wheel exposure may require deeper analysis of dis-
tinct astrocyte phenotypes, which have been reported to
switch during early vs. late remyelination in an auto-
immune model of demyelination in rats [85].
One potential explanation for these differences in Plp1
and GFAP analyses in the MRI and wheel cohorts could
be that wheel running may elicit an interaction between
the iNSC transplants and the host cells or tissue envir-
onment. An alternative to consider is the potential for
false positive results when the statistical power drops
below the conventional 80% level [86]. Due to the death
of one mouse, the power for the GFAP analysis in the
MRI iNSC cohort fell to 74.4%, yet with an effect size of
1.62 (Cohen’s d). The increase of Plp1 cells after iNSC
transplantation in the wheel cohort was 62.3%, with an
effect size of 1.09.
Stem cell-based therapeutics
The current approach of direct conversion of mouse
somatic cells, e.g. fibroblasts, into iNSCs provides stably
expandable populations, and is feasible for generating
human iNSCs [29–32]. Direct conversion of fibroblasts
circumvents the pluripotent state, which delivers autolo-
gous NSCs more rapidly than by iPSC-type reprogram-
ming and subsequent differentiation and is known to
reduce neoplastic potential and increase genomic stabil-
ity [87]. Human iNSC can be either derived by repro-
gramming from adult dermal fibroblasts [30] or
peripheral blood monocytes [32]. Preclinical research
has revealed an unexpected ability of iNSC therapies to
provide neurotrophic support and inhibit detrimental
host immune responses in vivo, after transplantation
into the chronically inflamed CNS [88].
After transplantation into chronic CPZ lesions, iNSCs
remained undifferentiated, or differentiated along oligo-
dendrocyte or astrocyte lineages; the tissue environment
significantly modulated glial differentiation (Fig. 10).
iNSCs did not appear to form substantial new myelin
within 2 weeks post-transplantation. Thus, iNSCs likely
improved function by stimulating endogenous cell re-
sponses. As with NSCs generated by other means, iNSCs
may exhibit beneficial paracrine effects on endogenous
cells [89].
A recent review of cell-based therapeutic strategies for
MS indicated that the preferred course of action for clin-
ical translation may be through beneficial paracrine effects
from stem cells, rather than direct cell replacement requir-
ing injections into multiple lesion sites [88, 90]. When ap-
plied to NSC therapeutics, most preclinical studies have
found cell replacement to be secondary to other “by-
stander” effects, in which transplanted NSCs modulate
homeostasis favoring neuroprotection and immunomodu-
lation via multiple mechanisms. NSCs in fact exert direct
neuroprotective action through the secretion of neuro-
trophic factors; NSCs also inhibit the peripheral and peri-
vascular activation of pro-inflammatory T cells, while
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increasing numbers of inflammatory T regulatory cells. In
the context of progressive MS, mechanisms of action of
NSCs on mononuclear phagocytes are emerging to be of
pivotal importance. Among these, the reprogramming of
pro-inflammatory mononuclear phagocytes through se-
questration of the immunomodulatory metabolite succin-
ate and secretion of PGE2 is common to both iNSCs and
NSCs [51].
Several studies have transplanted cells into the lateral
ventricle in the chronic CPZ model and reported benefi-
cial effects without direct cell replacement. Transplanting
neural precursor cells into the ventricle after chronic CPZ
stimulated the endogenous OP response and improved
CC remyelination [91]. Mesenchymal stem cells trans-
planted after chronic CPZ exhibited immunosuppressive
effects on cytokines, astrocytes and microglia; this ap-
proach also activated subventricular zone NSCs and in-
creased CC oligodendrocyte lineage cells, remyelination,
and ex vivo measures of conduction velocity [92, 93]. Fur-
thermore, NSC-Lingo-1-Fc cells, which antagonize Lingo-
1, injected via tail vein during chronic experimental auto-
immune encephalomyelitis effectively alleviated neuro-
logic symptoms [94]. These findings indicate beneficial
effects of stem cell transplants during chronic disease
across MS models. Recently, extensive remyelination in
the CPZ model was achieved with transplantation of hu-
man glial progenitor cells [95]. The human cells were
transplanted during periods of OPC amplification in post-
natal mice or at 4 weeks of CPZ ingestion, and so do not
address transplantation into a chronic host lesion environ-
ment. Remarkably, the transplanted cells generated wide-
spread myelin after a further 16 weeks of CPZ ingestion.
Study limitations
Certain limitations of the current study are important to
interpretation of the data. The chronic CPZ model pro-
vides a highly astrogliotic demyelinated lesion yet cannot
fully replicate the pathological mechanisms of demyelin-
ation and neurodegeneration of progressive MS [76]. In
addition, MS lesions are distributed within both white
matter and gray matter regions [76]. Some iNSCs were lo-
calized in cerebral cortex or hippocampus, which are re-
gions that can exhibit demyelination from CPZ [33, 96,
97], but our techniques were not designed for analysis of
gray matter sites. In MS populations, sex is an important
biological variable that cannot be appropriately examined
in the CPZ model in C57BL/6 mice since CPZ disrupts
the estrus cycle [36]. A 2-week period after transplantation
was used to capture early iNSC responses in this chronic
lesion environment while a longer interval could more
fully examine iNSC remyelinating potential. Furthermore,
comparison between mouse and human iNSC direct and/
or paracrine effects will be important in future studies.
Conclusions
These results show that iNSC transplantation can en-
hance recovery of function even in chronically demyeli-
nated white matter that already exhibits significant
atrophy. Our results suggest a combination of subtle
beneficial effects from interactions between iNSCs and
the lesion environment that promote functional recov-
ery. As cell replacement was not required, similar effects
may be achievable using small molecules and/or iNSC
exosomes [89].
Altogether, despite compelling preclinical evidence of
the therapeutic effects of transplantation in animal
models of demyelinating diseases, further research is
warranted to evaluate mechanism(s) of action from iNSC
transplantation, and how to exploit these mechanisms
for translation to treatments for progressive MS.
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